STUDY SEARCH RESULTS

1 study found for your search request:  7075-006

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Pr...
Condition: PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Minimum Age: 2 years, Maximum Age: 120 years
Gender: All
Study ID: NCT04980872
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site